Profile | GDS2987 / Hs.486649-S |
Title | Comparison of Rho kinase inhibitor and atorvastatin effects on primary cell lines |
Organism | Homo sapiens |
Sample | Title | Value | Rank |
---|---|---|---|
GSM214810 | HMVEC_vehicle_rep1 | 7.6 | 27 |
GSM215244 | HMVEC_vehicle_rep2 | 10.2 | 26 |
GSM215253 | HMVEC_vehicle_rep3 | ||
GSM215254 | HMVEC_atorvastatin_rep1 | 14.9 | 37 |
GSM215282 | HMVEC_atorvastatin_rep3 | 24.9 | 50 |
GSM215344 | HMVEC_atorvastatin_rep2 | 33.9 | 60 |
GSM215283 | HMVEC_atorvastatin_mevalonate_rep1 | 5.3 | 11 |
GSM215284 | HMVEC_atorvastatin_mevalonate_rep2 | 3.6 | 8 |
GSM215293 | HMVEC_atorvastatin_mevalonate_rep3 | 0.1 | 0 |
GSM215294 | HMVEC_SLx2119_rep1 | ||
GSM215295 | HMVEC_SLx2119_rep2 | ||
GSM215296 | HMVEC_SLx2119_rep3 | 16.4 | 27 |
GSM215297 | PASMC_vehicle_rep1 | ||
GSM215298 | PASMC_vehicle_rep2 | 4.8 | 8 |
GSM215310 | PASMC_vehicle_rep3 | 1.5 | 2 |
GSM215311 | PASMC_atorvastatin_rep1 | ||
GSM215312 | PASMC_atorvastatin_rep2 | 33.9 | 47 |
GSM215313 | PASMC_atorvastatin_rep3 | 27.9 | 39 |
GSM215324 | PASMC_atorvastatin_mevalonate_rep1 | 43.9 | 57 |
GSM215325 | PASMC_atorvastatin_mevalonate_rep2 | 16 | 30 |
GSM215326 | PASMC_atorvastatin_mevalonate_rep3 | 26.8 | 42 |
GSM215327 | PASMC_SLx2119_rep1 | 6.3 | 12 |
GSM215328 | PASMC_SLx2119_rep2 | 19.3 | 34 |
GSM215329 | PASMC_SLx2119_rep3 | 21.5 | 39 |
GSM215330 | Fibroblasts_vehicle_rep1 | 2.1 | 5 |
GSM215331 | Fibroblasts_vehicle_rep2 | 7.6 | 22 |
GSM215332 | Fibroblasts_vehicle_rep3 | 12.5 | 39 |
GSM215333 | Fibroblasts_atorvastatin_rep1 | 7.5 | 20 |
GSM215334 | Fibroblasts_atorvastatin_rep2 | 11.4 | 31 |
GSM215335 | Fibroblasts_atorvastatin_rep3 | 3.1 | 8 |
GSM215336 | Fibroblasts_atorvastatin_mevalonate_rep1 | 10.7 | 34 |
GSM215337 | Fibroblasts_atorvastatin_mevalonate_rep2 | 3.7 | 12 |
GSM215338 | Fibroblasts_atorvastatin_mevalonate_rep3 | 13.4 | 36 |
GSM215339 | Fibroblasts_SLx2119_rep1 | 4 | 12 |
GSM215340 | Fibroblasts_SLx2119_rep2 | 6.2 | 18 |
GSM215341 | Fibroblasts_SLx2119_rep3 |